Spain's healthcare cull on hold, HTA and central procurement on track
This article was originally published in Scrip
Two significance projects aimed to cut healthcare costs in Spain got the go-head from regional governments on 3 October. The legislation needed to bring in the national health technology assessment (HTA) agency, which will be modelled on the UK's NICE, has been formally approved for passage into law; and there is progress with the planned expansion of the centralised vaccines-purchasing 'platform': a proposed list of target vaccine products is close to being unveiled. However, further cost-cutting measures were put on hold.
You may also be interested in...
The US FDA issued only one device-related close-out letter in October.
Seven pharmacies have filed a lawsuit against the FDA claiming the agency exceeded its statutory authority in its final standard memorandum of understanding on interstate compounding and that the MOU will have an adverse impact on compounding pharmacies and patients.
Several experts spoke with Scrip about their take on how the biopharmaceutical industry's efforts to respond to COVID-19 might help industry's image problem.